Therapeutic targeting of adenosine receptors in inflammatory diseases

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.4, Iss.4, 2000-08, pp. : 447-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting of Th1-Associated Chemokine Receptors CXCR3 and CCR5 as Therapeutic Strategy for Inflammatory Diseases

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1089-1096

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs modulating adenosine receptors as potential therapeutic agents for cardiovascular diseases

By Broadley K.J.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1669-1692

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases

Current Pharmaceutical Design, Vol. 21, Iss. 30, 2015-10 ,pp. : 4392-4399

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer

Current Pharmaceutical Design, Vol. 22, Iss. 41, 2016-12 ,pp. : 6209-6233

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine and Adenosine Receptors in the Pathomechanism and Treatment of Respiratory Diseases

Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. : 917-922

Bentham Science Publishers

Access to resources Recommend Favorite